Scientific Advisory Committee

The Scientific Advisory Committee (SAC) is composed of not less than 5 prominent scientists with expertise in various scientific disciplines relating to drug discovery and development, and/or to the specific reality of neglected diseases and patients. The committee operates independently of the Board of Directors and the Executive Team. The Board of Directors approves the selection of SAC members. The SAC has the mission to advise the Board of Directors on matters related to research and development and choice of projects as well as quality of the scientific production.

Pierre-Etienne Bost, Chair; formerly Institut Pasteur, France
Khirana Bhatt, University of Nairobi, Kenya
Chris Bruenger, IDEC, Japan
François Chappuis, Médecins sans frontières & Geneva university hospital
J Carl Craft, formerly with Medicines for Malaria Venture, Switzerland
Simon Croft, London School of Hygiene and Tropical Medicine, UK
Federico Gomez de las Heras, formerly with GlaxoSmithKline, Spain
Chitar Mal Gupta, Central Drug Research Institute, India
Maria das Graças Henriques, Farmanguinhos/Fiocruz, Brazil
Paul Herrling, Novartis International AG, Switzerland
Dale Kempf, Distinguished Research Fellow and Director of Antiviral Research, Abbott 
Nor Shahidah Khairullah, Infectious Diseases Research Center, Malaysia
Shiv Dayal Seth, Indian Council of Medical Research (ICMR)
Nilanthi de Silva, University of Kelaniya, Sri Lanka
Faustino Torrico, Universidad Mayor de San Simon, Cochabamba, Bolivia
Mervyn Turner, formerly with Merck research laboratories
Muriel Vray, Institut Pasteur, France
Krisantha Weerasuriya, World Health Organization (WHO), Switzerland